Long Term Cardiovascular Safety of Testosterone Therapy: A Review of the TRAVERSE Study
TRAVERSE (TheRapy for Assessment of long-term Vascular events and Efficacy ResponSE in hypogonadal men) is multicentre randomized, double-blind, placebo-controlled, noninferiority trial of testosterone therapy, enrolling 5,246 men 45 to 80 years of age who had pre-existing or a high risk of cardio...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Korean Society for Sexual Medicine and Andrology
2025-04-01
|
| coleção: | The World Journal of Men's Health |
| Assuntos: | |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|